Just Medicine

Just Medicine is a non-profit biotechnology company dedicated to democratizing access to essential medications through decentralized, automated manufacturing. The organization is developing the 'Medicine Maker,' a hardware platform designed to synthesize high-demand, off-patent drugs at a fraction of their current market price. By utilizing an open-source approach to pharmaceutical production, Just Medicine aims to bypass traditional supply chain inefficiencies and provide direct access to life-saving treatments. Their initial focus includes addressing the high cost and supply shortages of GLP-1 receptor agonists, such as semaglutide, for the treatment of obesity and diabetes. Operating as a 501(c)(3) non-profit, the company prioritizes global health equity and the 'right to repair' for medicine. This innovative model seeks to empower local communities and healthcare providers to produce critical drugs on-site, ensuring availability regardless of market fluctuations.